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Rheumatoid arthritis (RA) patients with comorbid fibromyalgia (FM) manifest alterations 
in brain connectivity synonymous with central sensitization.  Here we consider how 
peripheral inflammation, the principal nociceptive stimulus in RA, interacts with brain 
connectivity in RA patients with comorbid FM. 
Methods: 
RA patients with (FM+, n=27) and without (FM-, n=27) comorbid FM completed 
functional connectivity magnetic resonance imaging.  Seed to whole-brain functional 
connectivity analyses were conducted using left mid/posterior insula and left inferior 
parietal lobule (IPL) seeds, regions previously linked to FM symptoms and inflammation 
respectively.  The association between functional connectivity and erythrocyte 
sedimentation rate (ESR) was assessed in each FM group separately, followed by post-
hoc analyses to test for interaction effects.  Significance was set at a cluster-level 
family-wise error (FWE) rate of p < 0.05.   
Results:  
RA patients with and without FM did not differ by age, gender or ESR (p > 0.2).  In FM+ 
RA patients, increased insula - left IPL, left IPL - dorsal anterior cingulate and left IPL - 
medial prefrontal cortex functional connectivity correlated with higher levels of ESR (all 
p < 0.05 FWE).  Post-hoc interaction analyses largely confirmed that the relationship 
between ESR and connectivity changes as FM scores increase. 
Conclusion: 
Here we provide the first neurobiological evidence that comorbid FM in RA may be 
linked to peripheral inflammation through pro-nociceptive patterns of brain connectivity.  
In patients with such ‘bottom-up’ pain centralization, comorbid symptoms may partially 











Rheumatoid Arthritis (RA) is known for its heterogeneous clinical presentation, with 
some patients reporting pain localized to affected joints and others reporting widespread 
hyperalgesia, fatigue, and cognitive difficulties.  This latter phenotype bears remarkable 
similarities to fibromyalgia (FM) and indeed the prevalence of comorbid FM ranges 
between 12-48% in RA compared to 2-8% in the general population [1]. Moreover, we 
recently showed that one of the chief neurobiological signatures of FM, increased 
default mode network (DMN) to insula functional connectivity, also occurs in RA patients 
in proportion to their comorbid FM symptoms [2].   
In the context of RA, it has long been hypothesized that peripheral inflammatory 
nociceptive processes sensitize the central nervous system (CNS) via pro-nociceptive 
CNS pathways and drive the appearance of comorbid FM [3].  This suggests that 
individual differences in how the brain responds to inflammation may be critical to 
understanding concomitant FM in RA.    
We recently provided some of the first evidence that functional brain connections are 
substantially altered in RA patients with high levels of peripheral inflammation [4].  Here 
we expanded that effort by exploring the interaction between FM symptoms and 
inflammation on functional brain connectivity in the same cohort of RA patients.  These 
analyses were designed to identify patterns of brain connectivity in RA that promote 
core symptoms of FM in response to inflammation.  We hypothesized that higher 
inflammation would be associated with distinct changes in connectivity from the insula 
(a pro-nociceptive brain region) and left inferior parietal lobule (IPL; a region associated 
with the neural response to peripheral inflammation in RA patients) to other brain 
regions in patients with high levels of FM symptoms. 
METHODS: 
Participants: 
RA patients were approached through a UK regional rheumatology service.  
Participants were considered eligible if they met the 2010 American College of 
Rheumatology/European League Against Rheumatism (ACR/EULAR) classification 
criteria [5]. This study was designed to examine the neural correlates of fatigue in RA, 
therefore patients had to have a clinically significant level of fatigue for at least 3 months 
(defined as a score > 3 on the Chalder fatigue binary scale).  The analyses presented 
here address alternate hypotheses regarding inflammation and centralized pain in RA. 
Exclusion criteria were contra-indications to MRI, left-handedness, or an alternative 
medical explanation for fatigue. A total of 73 patients fulfilled these criteria, and 54 RA 
patients (41 female) completed the entire study. The North of Scotland Research Ethics 
Committee gave ethical approval for the study.  All participants provided written 




All consenting participants underwent a clinical evaluation and a functional MRI (fMRI) 
brain scan. FM diagnosis was assessed using the ACR FM survey criteria which 
combines a measure of widespread pain (number of painful sites [0-19]) with a 
symptom severity scale (e.g., fatigue, subjective cognitive problems, headache, poor 
mood; scores range from 0-12) [6].  A combined score of 13 or greater was used as the 
diagnostic cutoff for FM [6].  27 RA patients met criteria for FM (FM+) and 27 RA 
patients did not (FM-).  Inflammation was measured using the erythrocyte sedimentation 
rate (ESR), a measure of systemic inflammation, which is commonly used to diagnosis 
and monitor chronic inflammatory diseases such as RA.  A trained phlebotomist 
performed a venous blood draw during normal clinic hours (9 a.m. – 5 p.m.) and the 
blood was immediately processed and analyzed for the calculation of ESR (Westergren 
method).   
fMRI Data Acquisition and Preprocessing: 
fMRI data were collected using a 3 Tesla scanner (Achieva X-series, Philips Medical, 
Best, The Netherlands) and 8 channel phased array head coil.  Each participant 
completed an 11-minute functional scan while performing the Paced Auditory Serial 
Attention Test (PASAT), a validated measure of cognitive function. The PASAT was 
given in a block design with 3x3 minute ‘on’ periods, interspersed with 4x30 second rest 
or ‘off’ periods.  During the ‘on’ periods, a series of numbers were audibly presented. 
Participants were asked to sum consecutive numbers and to press a button every time 
the numbers summed to 10.  Concurrently, patients were shown a distracting visual 
stimulus of random, rapidly changing numbers meant to increase task difficulty.  The 
functional images were acquired by a using a three-dimensional (3D) T2*-weighted 
gradient-echo single-shot echo-planar imaging pulse sequence with the following 
parameters: TR = 3000 ms, TE = 30 ms, flip angle (FA) = 90°, in-plane SENSE 
acceleration 2, field of view (FOV) = 240 mm, matrix size 128×128 with 30 slices, 
1.88×1.88×5 mm3 voxels and 226 volumes.  A high-resolution structural T1-weighted 
fast-field echo 3D structural scan was collected for normalization (TR = 8.2 ms, TE = 3.8 
ms, TI = 1018 ms, FA = 8°, FOV = 240 mm, matrix size 240×240 with 160 slices, and 
0.94×0.94×1 mm3 voxels). 
fMRI data were preprocessed using SPM8 (Wellcome Department of Cognitive 
Neurology, London, United Kingdom) running on MATLAB R2014a (Mathworks, 
Sherborn, MA, USA), as previously described [2, 4]. Briefly, the first four volumes were 
discarded to avoid equilibration effects, and the remaining 222 functional images were 
realigned to the first.  The structural image was co-registered to a mean functional 
image and then segmented.  The structural and functional scans were normalized to the 
standard SPM Montreal Neurological Institute template grey prior probability map via 
the individuals segmented grey matter image.  Functional scans were then smoothed 
with an 8-mm full-width half-maximum Gaussian kernel.  
Seed to whole brain connectivity analysis:  
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In these same RA patients, we have shown that DMN - left mid/posterior insula 
connectivity is associated with the FM survey criteria score [2], and that the left IPL is 
more connected to multiple brain networks in patients with high levels of inflammation 
[4].  To determine how FM and inflammation interact in the brain, we used these same 
left insular and IPL clusters as seed regions (Fig 1A and Fig 2A).  The preprocessed 
functional data were entered into the Functional Connectivity Toolbox (CONN; Cognitive 
and affective neuroscience laboratory, Massachusetts Institute of Technology, 
Cambridge, MA, USA; www.nitrc.org/projects/conn) v15.  As previously described [2, 4], 
a nuisance regression model using the CompCor method was performed with six 
subject-specific motion parameters, the signal from white matter and CSF, and their first 
order derivatives included as confounds.  A band pass filter (0.01-0.1 Hz) was applied to 
remove linear drifts and high frequency noise in the data. Task and rest onset periods 
were modelled and concatenated in first-level analyses to generate beta maps 
representing connectivity between the insula and IPL and the rest of the brain during 
task and rest conditions.  The resulting beta maps were passed onto second-level group 
analyses in SPM8.  Rest periods were not analysed at the group level because the 
summed resting condition (2 minutes) is too short for reliable connectivity estimates [7]. 
The FM+ and FM- groups were assessed independently using multiple regression 
models in SPM8. In each group we assessed the relationship between seed-to-whole 
brain connectivity and ESR with age and sex included as covariates of no interest.  The 
resulting maps were thresholded at an uncorrected voxelwise level of p < 0.001, and 
significance was set at p < 0.05 family wise error (FWE) cluster corrected for multiple 
comparisons.  The average fisher transformed r values of significant clusters were 
extracted from the first level beta maps for each subject for secondary analyses to test 
for interaction effects.   
Post-hoc Interaction Analyses: 
To formally test the possibility of interaction effects, we examined whether the 
relationship between extracted connectivity values from significant clusters (as 
described above) and ESR changes as a function of FM total scores. Total scores, 
rather than FM clinical cutoffs were used as we have previously shown that this 
construct can be used continuously[2]. ESR and FM survey scores were standardized 
and centered.  These analyses were conducted with general linear models in R version 
3.4.4.   
Finally, we performed post-hoc Spearman rank-order correlations between functional 
connectivity and CRP to confirm the relationships seen with ESR. 
RESULTS: 
Clinical characteristics: 
The clinical characteristics of this sample has been described previously [2, 4] and are 
shown in Supplementary Table 1 for FM+ and FM- groups separately.  27 RA patients 
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met criteria for FM. The mean FM score in the FM+ RA patients was 17.89  4.77, and 
8.52  3.19 in the FM- patients.  There was no significant difference between FM+ and 
FM- RA patients in age, gender, or ESR.  
Seed to whole-brain connectivity analyses: 
In FM+ RA patients, higher levels of peripheral inflammation were associated with 
increased functional connectivity between the insula and the left mid frontal gyrus 
(MFG) and the left IPL (Fig 1B-D, Table 1).  Further, in FM+ RA patients, higher 
peripheral inflammation was associated with increased functional connectivity between 
the left IPL and multiple cortical regions, including the dorsal anterior cingulate cortex 
(ACC), medial prefrontal cortex (mPFC), right MFG, right superior frontal 
gyrus/supplementary motor area and left IPL (adjacent to the seed IPL region) (Fig 2B-
D, Table 1). Of the seven connections associated with ESR in FM+ patients, four were 
significant or marginally significantly associated with CRP (Supplementary Table 2).   
In FM- RA patients, higher levels of peripheral inflammation were correlated with lower 
functional connectivity between the insula and right IPL, and higher functional 
connectivity between the IPL and left superior temporal gyrus (Table 1).   
It is possible that other aspects of disease activity, such as the swollen and tender joint 
counts (SJC, TJC) that are incorporated into the DAS28, could be affecting the results.  
We therefore conducted partial correlation analyses between the extracted connectivity 
values and ESR while controlling for SJC and TJC, separately in the FM + and FM – 
groups.  There were no appreciable changes in the strength of the association between 
ESR and connectivity in these analyses (data not shown). 
Additionally, adjusting for BMI did not alter the associations between ESR and 
connectivity in either group (data not shown).  
Post-hoc Interaction Analyses: 
There was a significant interaction effect between FM scores and ESR for each 
extracted connectivity value (all p < .05; Table 1) except for the IPL to R MFG (p = 
.317), suggesting that the interaction between FM symptoms and inflammation is 
important whether or not a patient meets epidemiological criteria for FM.  
DISCUSSION 
In RA, peripheral inflammation appears to interact with FM status on measures of brain 
functional connectivity.   In our previous study [2] we demonstrated that a 
neurobiological signature of pain centralization, enhanced insula to DMN connectivity, is 
also present in RA.  Importantly, across the overall sample, this connectivity was not 
significantly associated with peripheral inflammation.  Here we show for the first time 
that inflammation is neurobiologically associated with other more established patterns of 
pro-nociceptive connectivity in RA, but selectively in those patients with more FM 
symptoms. These effects were apparent when FM was measured as a continuous 
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construct, suggesting that FM symptoms may have important neurobiological correlates 
whether or not a patient meets clinical criteria for FM as we have previously reported 
[2].  This suggests that there is an interaction between peripherally enhanced 
sensitization and centrally-maintained sensitization that contributes to FM symptoms in 
RA.  Put simply, how the brain responds to peripheral inflammation may be critical for 
understanding why some RA patients have high levels of comorbid FM symptoms while 
others do not.         
The insula is a multi-modal sensory processing region and critically involved in pain 
perception [8].  In FM+ RA patients, increased insula – left IPL connectivity was 
positively correlated with peripheral inflammation.  The IPL is a key node of the DMN 
and heightened DMN-insula connectivity is an established neurobiological feature of FM 
[8], and in these same RA patients with high levels of FM symptoms [2].  In FM+ RA 
patients, we would expect to see increased DMN-insula functional connectivity, but the 
relationship with peripheral inflammation observed here is novel.  Interestingly, this left 
IPL region overlapped with the IPL cluster we previously identified as being more 
strongly connected to multiple brain networks in patients with high peripheral 
inflammation [4].   
Using the IPL cluster from our previous study [4] as a seed region, we found that IPL – 
dorsal ACC and mPFC functional connectivity was positively associated with 
inflammation only in FM+ RA patients.  It has been previously shown that FM patients 
have higher activity in the dorsal ACC compared to healthy participants during a painful 
task [9].  A previous study in RA patients found that the dorsal ACC, mPFC and left IPL 
were activated during a provoked joint pain paradigm, and that the mPFC and left IPL 
were functionally connected during this painful task [10].  In this context, our results may 
indicate preliminary evidence of the integration of inflammation-linked brain connectivity 
and classic pro-nociceptive brain connectivity. 
In FM- RA patients, insula – right IPL functional connectivity was negatively correlated 
with peripheral inflammation, while in FM+ patients there was a positive correlation with 
the left IPL.  There is evidence of hemispheric asymmetry in IPL function [11] and in the 
susceptibility to neurodegeneration. For instance, the left hemisphere is affected earlier 
and more severely in Alzheimer’s disease and the left (compared to right) IPL shows 
greater metabolic dysfunction in early dementia [11].  The left IPL may be more 
susceptible to peripherally enhanced sensitization which is why inflammation-associated 
connectivity changes in this region are predominately in patients with comorbid FM. 
This is the first study to examine patterns of inflammation-associated brain connectivity 
in the context of concomitant FM in RA.  Although the evidence is limited, FM symptoms 
co-existing with another disorder is thought to constitute two broad processes. First, a 
‘bottom-up’ form of central sensitization driven primarily by ongoing nociceptive input 
and so somewhat responsive to treatments that target peripheral nociceptive drivers. 
Second, a ‘top-down’ central sensitization sub-type which is primarily central in origin 
and so unaffected by manipulations of peripheral nociception [3].  Consistent with this 
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hypothesized distinction, a previous osteoarthritis study indicated that successful joint 
replacement surgery resulted in a substantial improvement of responses to 
experimental pain measures outside the surgical site and patients whose surgery 
eliminated their pain showed a more normal inhibitory response to evoked pain than 
they did prior to surgery [12].  In RA, the analogous phenomenon would involve 
improvement in concomitant FM symptoms following successful inflammatory inhibition. 
Future studies will focus on patterns of inflammation-associated brain connectivity that 
predict improvement in concomitant FM after inflammation-dampening therapy. 
This study has limitations.  First, all of the RA participants in this study had significant 
levels of chronic fatigue which may not necessarily be representative of all patients and 
could have biased the sample towards a centralized pain phenotype.  Second, we 
examined functional connectivity during the performance of a cognitive task from two 
seed regions based on earlier results in the same sample. Future studies should 
attempt a whole-brain agnostic approach in an independent sample while participants 
are at rest or performing other tasks.  We do not know when patients developed FM 
symptoms relative to the onset of RA; therefore, some patients may be part of a 
different phenotype wherein ‘top-down’ central sensitization exists prior to RA diagnosis. 
We have made the reasonable assumption that our measure of systemic inflammation 
(ESR) is derived entirely from the well-established peripheral immune dysfunction which 
characterizes RA.  However, considering the evolving evidence supporting a neural 
inflammatory reflex [13], it is also possible that altered brain connectivity drives 
peripheral inflammation, perhaps via endocrine pathways. It would be intriguing to 
evaluate the responsiveness of the identified pro-nociceptive connectivity in the context 
of a peripherally directed anti-inflammatory therapeutic, as mentioned above. In a small 
study of TNF inhibition (TNFi) in RA, Rech et al. (2013) demonstrated that pro-
nociceptive brain connectivity decreased rapidly (i.e., 3 days) after the commencement 
of TNFi treatment, and before a positive clinical response was observed [14], providing 
some support for the concept of bottom-up sensitization. Ultimately, the great clinical 
value of distinguishing ‘bottom-up’ mechanisms of central sensitization is the potential to 
mark out RA patients whose FM symptoms may improve with an enhanced peripheral 
immunosuppressive approach.  In contrast, ‘top-down’ central sensitization would not be 
expected to respond to peripherally directed therapies, rather patients may receive 
benefit from centrally acting interventions. Until more definitive studies are conducted, 
these remain working hypotheses.   
Our finding that peripheral inflammation enhances connectivity in established pro-
nociceptive pathways provides preliminary neurobiological evidence for a distinct FM-
like sub-type in RA.  Identifying the neurobiological patterns associated with different 
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Figure 1. Increased brain connectivity between the left mid/posterior insula (A) and the 
left IPL (B) was correlated with higher levels of peripheral inflammation in RA patients 
that met criteria for fibromyalgia (FM+).  The inset shows the overlap of the left IPL 
cluster with previous results [4] showing that numerous brain networks were 
hyperconnected to the same region of the IPL in RA patients with high inflammation.  
Scatterplots of the correlations between ESR and insula – IPL connectivity are depicted 
separately for FM+ and FM- RA patients in (C).  There was also a significant positive 
relationship in FM+ RA patients between insula – left MFG connectivity and peripheral 
inflammation (D).   
IPL, inferior parietal lobule; MFG, middle frontal gyrus; ESR, erythrocyte sedimentation 
rate; Ins, insula; FC, functional connectivity 
 
Figure 2. In FM+ RA patients, there was a significant relationship between peripheral 
inflammation and functional connectivity between the left IPL and the dorsal ACC, 
mPFC, left IPL (adjacent to seed region), right SFG/SMA and right MFG (B).  
Scatterplots of the correlations between ESR and IPL – mPFC and IPL – dorsal ACC 
connectivity are depicted in (C) and (D), respectively.  
IPL, inferior parietal lobule; dACC, dorsal anterior cingulate cortex; mPFC, medial 
prefrontal cortex; SFG, superior frontal gyrus; SMA, supplementary motor area; MFG, 






Table 1: Associations between seed-to-whole brain functional connectivity and ESR 
FM+ 















P value for post-
hoc interaction 
L Insula  
L mid frontal gyrus (+) -36, 24, 32 4.38 161 0.007 0.049 
L IPL (+) -50, -50, 40 3.98 132 0.019 0.015 
L IPL 
Bilateral Dorsal ACC/mPFC (+) 2 38 36 4.43 239 0.001 0.016 
R mid frontal gyrus (+) 30 48 2 4.31 132 0.026 0.317 
Bilateral SFG/SMA (+) 8 28 52 4.15 128 0.030 0.040 
R mPFC/R Dorsal ACC (+) 12 60 30 3.88 349 0.000 0.002 
L IPL (+) -32 -48 46 3.76 135 0.023 0.016 
FM- 















P value for post-
hoc interaction 
L Insula  
R IPL/Precuneus/Angular (-) 28, -52, 44 4.51 175 0.002 <.001 
L IPL 
L STG (+) -50 -42 6 4.29 257 0.000 0.024 
 
 
  
 
